Spire Healthcare Demands Sale

Spire Healthcare, a private hospitals operator, is being urged by its leading investors to put itself up for sale. The company’s shareholders, including Achilles, are exploring discussions with potential bidders.

Current Situation

Achilles, an activist investment trust co-founded by City Fund Manager, holds around 5% of Spire shares. Along with other investors, they believe the company is significantly undervalued. Spire operates 38 hospitals and over 50 clinics, medical centers, and advisory rooms across Great Britain, making it the largest provider of hip and knee operations in the country.

Company Overview

The company, led by Managing Director Justin Ash and headed by City Grandee Sir Ian Cheshire, has a market capitalization of almost £820 million. However, its real estate assets alone are valued at over £1.4 billion. This significant disparity has led investors to push for a sale to maximize shareholder value.

Plans for the Future

Achilles has informed the company of its intention to commission consultants to carry out a formal sales process. In its July results, Spire stated that its board would "continue to actively evaluate and implement all suitable measures to deliver long-term shareholder value." As of Wednesday, it was unclear whether formal approaches had been received by the Spire board.

Response from Investors

Achilles declined to comment on the situation, while Spire was contacted for a statement. The push for a sale underscores the investors’ belief that the company’s current valuation does not reflect its true worth, particularly given the value of its real estate assets.